Acute Ocular Pain Market Report by DelveInsight
DelveInsight's "Acute Ocular Pain Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acute Ocular Pain , historical and forecasted epidemiology as well as the Acute Ocular Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Eye pain is a
myriad of symptoms ranging from a sharp pain in the eye to mild discomfort or
itching in the eyes. As the spectrum of symptom presentation varies with eye
pain, the cause of these pains may vary from straightforward refractive errors
to potentially sight-threatening disorders like glaucoma and uveitis. A feeling
of discomfort or pain in the eye can be caused by a problem in the eye itself.
Some key facts of Acute
Ocular Pain Market Report are:
- Acute Ocular Pain Market
Size in the 7MM was estimated to be USD 276.02 million in
2020, and it is estimated to grow at a Compound Annual Growth Rate (CAGR)
of 8.93% for the study period (2018–2030).
- In
the year 2020, the total cases of Acute Ocular Pain (AOP) were estimated
to be 15,029,051 cases in the 7MM, which might increase
in 2030 at a CAGR of 0.65%.
- According
to DelveInsight estimates, in 2020, it was estimated that there were 461,948,
14,243, 98,281, 710,949, 1,268,905 and 4,050,494 cases of
Cataract Surgeries, Uveitis, Glaucoma Surgeries, Corneal Aberration
Surgeries, Dry eye disease, and Conjunctivitis respectively that
experienced acute ocular pain, in the United States.
- Among
EU5 countries, Spain has the lowest number of cases of Acute Ocular Pain
(AOP), which were estimated to be 1,106,840 cases in
2020.
·
Dextenza, Inveltys, and Lotemax SM—already
approved in the US market—are expected to enter the European and Japan market
in 2023, 2024, and 2024, respectively.
Request for Free
Sample Report: https://www.delveinsight.com/report-store/acute-ocular-pain-market
Scope of the Acute
Ocular Pain Market Report
- The
report covers the descriptive overview of AOP, explaining its causes, symptoms,
pathophysiology, genetic basis, and currently available therapies.
- Comprehensive
insight has been provided into the AOP epidemiology and treatment.
- Additionally,
an all-inclusive account of both the current and emerging therapies for
AOP is provided, along with the assessment of new therapies, which will
have an impact on the current treatment landscape.
- A
detailed review of the AOP market; historical and forecasted is included
in the report, covering the 7MM drug outreach.
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the 7MM AOP market.
Some of Acute
Ocular Pain Companies
are:
·
Ocular Therapeutix
·
Kala Pharmaceuticals
·
Sun Pharmaceutical
·
Bausch & Lomb
·
Formosa Pharmaceuticals
·
Aldeyra Therapeutics
·
Sylentis
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/report-store/acute-ocular-pain-market
Acute
Ocular Pain therapies
are:
·
Dextenza (dexamethasone ophthalmic insert)
·
Inveltys (loteprednol etabonate ophthalmic
suspension/KPI-121)
·
BromSite (bromfenac ophthalmic solution)
·
Lotemax SM (loteprednol etabonate ophthalmic
gel)
·
Prolensa (bromfenac ophthalmic solution) 0.07%
·
APP13007
·
Reproxalap
·
Tivanisiran (SYL1001)
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/report-store/acute-ocular-pain-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Acute Ocular Pain
3. Competitive
Intelligence Analysis for Acute Ocular Pain
4. Acute Ocular Pain
: Market Overview at a Glance
5. Acute Ocular Pain
: Disease Background and Overview
6. Patient Journey
7. Acute Ocular Pain
Epidemiology and Patient Population
8. Treatment Algorithm,
Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Acute Ocular Pain Treatment
11. Marketed
Products
12. Emerging
Therapies
13. Acute Ocular
Pain : Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market Outlook
16. Access and
Reimbursement Overview of Acute Ocular Pain
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
Related Reports:
- Thymic
Carcinoma Market
- Asphyxia
Market
- Acute
Agitation And Aggression Market
- HPV-Induced
Cancers Market
- Diagnostic
Imaging Equipment Market
- Epilepsy
Market
- Bradykinesia
Market
- Immunologic
Deficiency Syndrome Market
- Wilms
Tumor Market
- Advanced
Wound Care Market
- Defibrillators
Market
- Diagnostic
Imaging Equipment Market
- Pulse
Oximeters Market
- Achromatopsia
Market
- Cataplexy
Market
Related Blogs:
- Gene
Therapy for Hemophilia: Progress and Setbacks
- IgA
Nephropathy – In-depth Assessment of the Emerging Therapies and Key
Companies in the Therapeutics Domain
- Smart
Hospital: How it is Shaping the Future of Healthcare Delivery
- An
in-depth Assessment of the Top Drugs Launched by Leading Global Companies
in 2021
About DelveInsight
DelveInsight Business Research is a leading Market Research, and
Business Consultant focused purely on Healthcare. It helps pharma companies by
providing them with end-to-end services to solve their business problems.
Know more about our competitive
intelligence services.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment